State Opportunities to Address Prescription Drug Costs in Medicaid

This is the resource list for the briefing on May 11, 2018 focused on State Opportunities to Address Prescription Drug Costs in Medicaid.

Friday, May 11, 2018

Key Resources (listed chronologically, beginning with the most recent)

“Efforts to Cut Drug Prices in Medicaid.” Dworkowitz, A. Manatt on Health: Medicaid Addition. February 27, 2018. Available at http://allh.us/mTjW.

“Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control.” Young, K. and Garfield, R. Kaiser Family Foundation. February 21, 2018. Available at http://allh.us/uHmB.

“Lower Drug Costs: The Next Frontier for State Flexibility.” Riley, T. Health Affairs Blog. February 16, 2018. Available at http://allh.us/kGFD.

Additional Resources (listed chronologically, beginning with the most recent)

“Statewide Prescription Drug Database: 2015-Present.” National Conference of State Legislatures. April 24, 2018. Available at http://allh.us/3Tha.

“New York’s Medicaid Drug Cap: A Look at the State’s New Effort to Manage Pharmaceutical Spending.” Issue Brief. The PEW Charitable Trusts. April 2, 2018. Available at http://allh.us/WjUw.

“Rising Prescription Drug Costs: A Report on State and Federal Efforts to Contain Costs.” Public Consulting Group. March 2018. Available at http://allh.us/rkFa.

“Overcoming Barriers to Value-Based Contracting in Medicaid.” Holderread, B., Cothran, T., Nesser, N. et al., The University of Oklahoma College of Pharmacy. February 26, 2018. Available at http://allh.us/qQw3.

“In An Effort to Curb Drug Costs, States Advance Bills to Prod Feds on Importation.” Luthra, S. Kaiser Health News. February 16, 2018. Available at http://allh.us/CKjW.

“Reigning in Rx Drug Costs: What States Achieved in 2017 and Where They’re Heading in 2018.” Alberts, C. State Health Policy Blog. National Academy for State Health Policy. December 19, 2017. Available at http://allh.us/yJFX.

“Curbing Unfair Drug Prices: A Primer for States.” Berman, A., Lee, T., Pan, A., Rizvi, Z., and Thomas, A. Global Health Justice Partnership. August 2017. Available at http://allh.us/pWk3.

“State Wholesale Importation Program Explained.” National Academy for State Health Policy. May 2017. Available at http://allh.us/fyC7.

“Medicaid Payment for Outpatient Prescription Drugs.” Issue Brief. Medicaid and CHIP Payment and Access Commission. March 2017. Available at http://allh.us/vEeh.

“Medicaid and Specialty Drugs: Current Policy Options.” Center for Evidence-based Policy: Oregon Health & Science University. June 2016. Available at http://allh.us/RF6P.

“Can Transparency Legislation Help Control Medication Costs?” Sarpatwari, A., Avorn, J. and Kesselheim, A. NEJM Catalyst. June 24, 2016. Available at http://allh.us/Erkq.

“Sticker Shock: Prescription Drug Affordability in Colorado.” Colorado Health Institute. June 17, 2016. Available at http://allh.us/7mth.

Jun24

past webinar

COVID-19 Webinar Series Session 20 - Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic  and Where We Go From Here

Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders examined the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.

Learn More

Share